Workflow
Akoya Biosciences(AKYA)
icon
Search documents
Akoya Biosciences(AKYA) - 2022 Q4 - Earnings Call Transcript
2023-03-07 05:00
Akoya Biosciences, Inc. (NASDAQ:AKYA) Q4 2022 Earnings Conference Call March 6, 2023 5:00 PM ET Company Participants Priyam Shah - Head, Investor Relations Brian McKelligon - Chief Executive Officer Joe Driscoll - Chief Financial Officer Conference Call Participants John Sourbeer - UBS Kyle Mikson - Canaccord Mason Carrico - Stephens Tejas Savant - Morgan Stanley Mark Massaro - BTIG David Westenberg - Piper Sandler Tim Chiang - Capital One Operator Thank you for standing by. And welcome to the Akoya Bioscie ...
Akoya Biosciences(AKYA) - 2022 Q4 - Annual Report
2023-03-06 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________ to ___________ Commission File Number: 001-40344 Akoya Biosciences, Inc. (Exact name of registrant as specified in its charter) Delaware 47-5586242 (St ...
Akoya Biosciences(AKYA) - 2022 Q3 - Earnings Call Transcript
2022-11-08 01:04
Akoya Biosciences, Inc. (NASDAQ:AKYA) Q3 2022 Earnings Conference Call November 7, 2022 5:00 PM ET Company Participants Priyam Shah - Senior Director, Investor Relations Brian McKelligon - Chief Executive Officer Joseph Driscoll - Chief Financial Officer Conference Call Participants Mason Carrico - Stephens Mark Massaro - BTIG Neil Vibhakar - Morgan Stanley Operator Good day and thank you for standing by. Welcome to the Akoya Biosciences Third Quarter 2022 Earnings Conference Call. At this time, all partici ...
Akoya Biosciences(AKYA) - 2022 Q2 - Earnings Call Transcript
2022-08-09 02:38
Akoya Biosciences, Inc. (NASDAQ:AKYA) Q2 2022 Earnings Conference Call August 8, 2022 5:00 PM ET Company Participants Priyam Shah - Head of IR Brian McKelligon - CEO Joseph Driscoll - CFO Conference Call Participants Neil Vibhakar - Morgan Stanley Kyle Mikson - Canaccord Genuity Mark Massaro - BTIG David Westenberg - Piper Sandler Operator Thank you for standing by, and welcome to the Akoya Biosciences Second Quarter 2022 Earnings Conference Call. At this time, all participants are in listen-only mode. Af ...
Akoya Biosciences(AKYA) - 2022 Q2 - Quarterly Report
2022-08-08 16:00
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________ to ___________ Commission File Number: 001-40344 Akoya Biosciences, Inc. (Exact name of registrant as specified in its charter) 4 ...
Akoya Biosciences(AKYA) - 2022 Q1 - Earnings Call Transcript
2022-05-08 11:42
Akoya Biosciences, Inc. (NASDAQ:AKYA) Q1 2022 Earnings Conference Call May 5, 2022 5:00 PM ET Company Participants Priyam Shah - Head of IR Brian McKelligon - CEO Joe Driscoll - CFO Conference Call Participants Dave Westenberg - Piper Sandler Edmund Tu - Morgan Stanley Operator Welcome to the Akoya Biosciences First Quarter 2022 Earnings Conference Call. [Operator Instructions] As a reminder, today's call is being recorded. I would now like to turn the conference over to your host, Mr. Priyam Shah, Head of ...
Akoya Biosciences(AKYA) - 2021 Q4 - Earnings Call Transcript
2022-03-15 03:18
Akoya Biosciences, Inc. (NASDAQ:AKYA) Q4 2021 Earnings Conference Call March 14, 2022 5:00 PM ET Company Representatives Brian McKelligon - Chief Executive Officer Joe Driscoll - Chief Financial Officer Priyam Shah - Head of Investor Relations Conference Call Participants Kyle Mikson - Canaccord Genuity Tejas Savant - Morgan Stanley Julia Qin - JP Morgan Dave Westenberg - Piper Sandler Operator Thank you for standing by, and welcome to Akoya Biosciences' Fourth Quarter 2021 Earnings Conference Call. At this ...